SPIA
NERV icon

Steward Partners Investment Advisory’s Minerva Neurosciences NERV Stock Holding History

Steward Partners Investment Advisory’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-6
Closed -$146 – 7294
2021
Q1 		$146 Buy
+6
New +$150 ﹤0.01% 3380

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Steward Partners Investment Advisory's NERV Position: Q2 2021 in Review

Steward Partners Investment Advisory sold out of Minerva Neurosciences (NERV) in Q2 2021, closing a stake of 6 shares — an estimated $146 sold.

Steward Partners Investment Advisory first reported a position in NERV in Q1 2021 and held it in 1 quarter. The position peaked at $146 in Q1 2021. 68 funds tracked by Wall St. Rank hold NERV as of Q2 2021.

  • Steward Partners Investment Advisory reported no remaining Minerva Neurosciences position as of Q2 2021 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 6 Minerva Neurosciences shares in Q2 2021, an estimated $146.
  • Steward Partners Investment Advisory first reported a position in Minerva Neurosciences in Q1 2021 and held it in 1 quarter.
  • Steward Partners Investment Advisory's Minerva Neurosciences position peaked at $146 in Q1 2021.
  • 68 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q2 2021.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2021, filed 13 Aug 2021.